Scholars Central

Conference abstractPublished 6 Oct 2015

Fluorescent carbon dots as a theranostic agent for controlled drug release

Authors: Madhuri Sharon

Solapur University, India

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Photoluminescent carbon-dots are envisaged as drug delivery vehicle due to their high chemical stability, water solubility, resistance to photodegradation, biocompatibility, low toxicity and easily tuneable optical properties. Use of natural as well as chemical precursors for synthesis of crystalline C-dots and conjugates of C-dot+mesoporous silica and C-dot+gold nanorod using microwave assisted heating in alkaline environment and their use for delivery of therapeutic payloads is reported here. Sucrose density gradient centrifugation was used to separate C-dots from debris. Optical and morphological properties of the C-dots were confirmed by UVVis spectroscopy, Fluorescence spectroscopy, Raman, XRD and FE-SEM. C-dots were biocompatible against MDCK cells. Drugs studied include ciprofloxacin hydrochloride, Doxorubicin, Haloperidol and Curcumin. C-dots/drug+linker complex were dialyzed against nanopure water to remove unattached drug and characterized by FTIR and TGA. Drug loading efficiency and release kinetics were calculated as per different mathematical models. Cipro and C-dots conjugate enhanced the antimicrobial activity against both model gram positive and negative microorganisms. Bovine Serum Albumin protected C-dots and doxorubicin complex having Folic Acid (FA) as navigational molecules have shown âÂ?Â?First OrderâÂ?Â? release of drug. Moreover, epifluorescence microscopy of HeLa-cells exhibited bright green fluorescence due to internalization of C-dots specifically targeted with FA in HeLa cells. When C-dots and GNR complex was used for anchoring DOX via covalent and non-covalent pH sensitive chemical bonds it could load 94% drug that rapidly got released under the influence of near-infrared thus paving way for an efficient nano-carrier, for controlled drug release as well as for bio-imaging, thereby, serving as potential tool for theranostics.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Pharmacology & Biopharmaceutics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Pharmacology & Biopharmaceutics
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Madhuri Sharon”